Synthesis of Silver Nanoparticles for Antibacterial Activity against Staphylococcus Aureus and Escherichia Coli
In Recent year's medication obstruction is a quickly developing issue over the whole world in the treatment of infectious diseases. The widespread use of broad-spectrum antibiotics produced antibiotic resistance for many human bacterial pathogens. Anyway right now, nanotechnology research has been engaging more in restorative businesses with various advantages because of the way that surface area to volume proportion of Nanoparticles is quite large. In this exploration work, Silver Nanoparticles (AgNPs) are prepared by using a reducing agent like sodium borohydride and capping agent polyvinylpyrolidine.
The AgNPs were set up by the chemical reduction method. Nanotechnology has its own importance it eventually reduce dose and also have a superior bioavailability than larger particles. The prepared AgNPs were subjected to characterization like particle size, X-Ray diffraction. In addition, the AgNPs drawing much interest in account of their powerful antibacterial movement. The antibacterial activity of AgNPs checked against the bacterial culture of Staphylococcus Aureus and E, coli. The zone of inhibition AgNPs was checked against both microorganisms. The results of this study demonstrate antibacterial activity of AgNPs against the bacterial culture of Staphylococcus Aureus and E, coli.
2. Shinde N, Keskar N, & Agade P. Nanoparticles: Advances In Drug Delivery Systems, Research Journal of Pharmaceutical, Biological And Chemical Sciences.2012; 3(1):922-929.
3. Iravani S, Korbekandi H, Mirmohammadi S, & Zolfaghari B. Synthesis of Silver Nanoparticles: Chemical, Physical and Biological Methods, Res Pharm Sci. 2014; 9(6): 385–406.
4. Dhrisya C, Subramaniam S, Ramakrishnan S & Krishnaswamy S. Therapeutic Efficacy of Nanoparticles and Routes of Administration. Biomaterial Research 2019 ; 23(20):1-29.
5. Linlin W.,Chen H , & Longquan S. The Antimicrobial Activity of Nanoparticles: Present Situation and Prospects for the future, Int J Nanomedicines. 2017; 12:1227–1249.
6. Franci G, Falanga A. , Galdiero S. , Palomba L. , Rai M. , Morelli G. & Galdiero M. . Silver Nanoparticles as Potential Antibacterial Agents, Molecules. (2015); 20(5):8856-74.
7. Sang H.L & Bong HJ. Silver Nanoparticles: Synthesis and Application for Nanomedicine, Int J Mol Sci. 2019 ; 20(4): 865.
8. Tikam C. Anu K., Rita S.M. & Vinod Yadav, Mechanistic Basis Of Antimicrobial Actions Of Agnps, Front Microbial. 2016 ; (7) : 1831.
9. Jaya J, Arora S, Rajwade J &Omray P. Silver Nanoparticles in Therapeutics: Development of An Antimicrobial Gel Formulation for Topical Use, Molecular Pharma, 2009 :6(5): 1388-1401
10. Chengzhu L. * Yuchao Li,2 and Sie C.T, Bactericidal and Cytotoxic Properties of Silver Nanoparticles, International Journal Molecular Sci. 2019; 20(2): 449.
11. Wang L,Chen H & Longquan S. The Antimicrobial Activity of Nanoparticles: Present Situation and Prospects for the Future, International Journal of Nanomedicines. 2017; 12: 1227–1249.
12. Mamun U.R, Synthesis of Silver Nano Particles (Ag-Nps) and their Uses for Quantitative Analysis of Vitamin C Tablets, Dhaka Univ. J. Pharm,. Sci. 2013 ;(12): 29-33 .
13. Suriati G, Jaafar M & Azizan A. Synthesis of Silver Nanoparticles by Chemical Reduction Method: Effect of Reducing Agent and Surfactant Concentration, International Journal of Automotive and Mechanical Engineering , 2014;10(1):1920-1927.
14. Biswas P &Dey S. Research Article Effects and Applications of Silver Nanoparticles In Different Fields. International Journal of Recent Scientific Research,2015; 6(8), 5880-5883.
15. Natsuki J., & Natsuki T, Review of Silver Nanoparticles: Synthesis Methods property and Application. International Journal of Materials Science and Applications, 2015; 4(5):325-332.
16. Naheed A, &Sharma S, Green Synthesis Of Silver Nanoparticles Using Extracts of Ananas Comosus , 2012 ; Vol. 2(4),4797-4805
17. Sharma R., Chadha N, & Saini P. Determination of Defect Density, Crystallite Size and Number of Graphene Layers In Graphene Analogues Using X-Ray Diffraction and Raman Spectroscopy, Indian Journal of Pure & Applied Physics, 2017; 55(9), 625-629.
18. Desai L. Mankad V, Gupta S, & Jha P, Distribution of Agnps: UV-Visible Spectroscopic Assessment, Nanoscience and Nanotechnology Letters. 2012; (4), 30–34.
19. Adriana VE & Morelhao SL. Usage of Scherrer’s Formula in X-Ray Diffraction Analysis of Size Distribution in Systems of Monocrystalline Nanoparticles. 2019.
20. Cameron F. H. And Raymond E. S., ACS Nano 2019; 13 (7), 7359-7365.
21. Franci G., Falanga A & Galdiero S. Silver Nanoparticles As Potential Antibacterial Agents, Molecules. 2015; 20(5):8856-74.
22. Blessing A. Metal-Based Nanoparticles for the Treatment of Infectious Diseases, Molecules. 2017; 22(8), 1370.
23. Tikam C.D.,Kumar A ,Majumdar R.S & Yadav V. Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles Front ,Microbiol 2016 ; 7: 1831.
24. Patra J.& Baek KH. Antibacterial Activity and Synergistic Antibacterial Potential of Biosynthesized Silver Nanoparticles against Foodborne Pathogenic Bacteria along With Its Anticandidal and Antioxidant effects Front, Microbial. 2017.
25. Singh A. & Kaur K. Biological and Physical Applications of Silver Nanoparticles with Emerging Trends of Green Synthesis, Engineered Nanomaterials - Health and Safety.2019.
26. Parvekar P., Palaskar J , Metgud S, Maria R & Dutta S .The Minimum Inhibitory Concentration (MIC) And Minimum Bactericidal Concentration (MBC) of Silver Nanoparticles against Staphylococcus Aureus, Biomaterial Investigation In Dentistry, Tailor and Fransis.2020 ;7(1), 105-109.
27. Richard J.F. & Yitzhak T. Antibiotics and Bacterial Resistance In The 21st Century, Perspective In Medicinal Chemistry. 2014; 6, 25–64.
28. Salem HF, Eid KAM & Sharaf MA. Formulation and Evaluation of Silver Nanoparticles as Antibacterial and Antifungal Agents with a Minimal Cytotoxic Effect, International Journal of Drug Delivery. 2011; (3), 293-304.
29. O’Connor K., Formulation and Evaluation of Silver Nanoparticles as Antibacterial and Antifungal Agents, Drug Discovery. 2005; (4), 1005-1014.
30. Bulmer C, Margaritis A & Xenocostas A. Production and Characterization of Novel Chitosan Nanoparticles for Controlled Release of Rhu-Erythropoietin. Biochemical Engineering Journal. 2012; 68, 61–69.
31. Tiwari D.K, & Behari J, Biocidal Nature of Combined Treatment of Ag-Nanoparticle and Ultrasonic Irradiation in Escherichia coli. Advances in Biological Research. 2009, 3 (3-4), 89-95.
32. Chimankar O. P, Padole N .N , & Pawar N .R. Study of Enhancement of Ultrasonic Velocity in Methanol Based Silver Nanoparticle Suspension. Journal of Pure and Applied Ultrasonic2017;39(3):79-82
33. Vyavahare S, Padole N, Avari J, A Review : Silver Nanoparticles in Wound Healing. Europian Journal of Pharmaceutical and Medical Research,2021;8(8):212-218.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).